Latest Administration News

Page 14 of 200
Pilot Energy Limited and its subsidiaries have appointed voluntary administrators after failing to secure necessary funding or a strategic partner for their Cliff Head Carbon Storage Project. The company’s shares remain suspended on the ASX as administrators review options to preserve stakeholder value.
Maxwell Dee
Maxwell Dee
14 July 2026
Recce Pharmaceuticals has expanded its intellectual property footprint with a key patent granted in Vietnam for its RECCE® anti-infective drugs, reinforcing its presence in a critical Southeast Asian market grappling with high antibiotic resistance.
Victor Sage
Victor Sage
14 July 2026
Neurotech International has secured FDA clearance for its Investigational New Drug application for NTI164, enabling clinical development in the US and advancing its global registration and commercialisation plans.
Ada Torres
Ada Torres
14 July 2026
Pacific Edge edges closer to Medicare reimbursement for its bladder cancer tests while its Asia Pacific operations show rising test volumes and improved margins, signaling a path toward profitability.
Ada Torres
Ada Torres
14 July 2026
INOVIQ Limited hit a roadblock in expanding clinical validation of its EXO-OC™ ovarian cancer test due to unsuitable biobank samples, yet improved its diagnostic algorithm and progressed its CAR-exosome therapeutic program, maintaining a solid cash position of A$9.35 million.
Ada Torres
Ada Torres
13 July 2026
Adrad Holdings is investing $3 million to build a second factory in Thailand, aiming to boost capacity for its Heat Transfer Solutions business and streamline operations.
Victor Sage
Victor Sage
13 July 2026
OncoSil Medical has completed key manufacturing validation cycles with Cyclotek, paving the way for scalable Australian production of its OncoSil™ device. With a $2.1 million capital investment, the company aims to boost margins and supply chain control ahead of commercial launch in late 2026.
Ada Torres
Ada Torres
13 July 2026
CLINUVEL Pharmaceuticals secures Canadian marketing approval for SCENESSE®, expanding access to the only approved systemic photoprotective treatment for erythropoietic protoporphyria (EPP).
Victor Sage
Victor Sage
13 July 2026
Resimac Group Ltd (ASX:RMC) has explained the late filing of a director’s change of interest notice as an administrative oversight and plans refresher training to reinforce compliance.
Claire Turing
Claire Turing
9 July 2026
Renascor Resources' cost study estimates its hydrofluoric acid-free purification method can produce battery-grade graphite at about US$459 per tonne, positioning it as a competitive ex-China alternative to conventional HF-based processes.
Maxwell Dee
Maxwell Dee
9 July 2026
Eagle Mountain Mining’s joint venture with Nittetsu has contracted Boart Longyear for a 6,000-metre drilling campaign at Oracle Ridge, marking a significant step in exploring near-mine copper extensions and testing new geophysical targets.
Maxwell Dee
Maxwell Dee
9 July 2026
New Zealand Rural Land Company faces uncertainty as Kiwi Crunch Farms, a tenant accounting for nearly 6% of rental income, enters receivership. Additional leases tied to the same owner add to risk, prompting suspension of earnings guidance.
Eva Park
Eva Park
9 July 2026

Browse the archive

Full archive